Kamata Toshiko

Affiliation and department：

Research field (1)： Respiratory surgery

Research theme for competitive and other funds (3)：

2021 - 2024 A study on B cell biomarkers associated with checkpoint inhibitors in lung cancer
2014 - 2017 Development of a novel combination immunotherapy with NKT cells and antibody therapy
2013 - 2017 Improvement of damaged lung by type II alveolar epithelial cells with multipotency - for the purpose of clinical application of lung transplantation -

Papers (108)：

Hiroki Matsumoto, Hidemi Suzuki, Takahiro Yamanaka, Taisuke Kaiho, Atsushi Hata, Terunaga Inage, Takamasa Ito, Toshiko Kamata, Kazuhisa Tanaka, Yuichi Sakairi, et al. Anti-CD20 Antibody and Calcineurin Inhibitor Combination Therapy Effectively Suppresses Antibody-Mediated Rejection in Murine Orthotopic Lung Transplantation. Life (Basel, Switzerland). 2023. 13. 10
Fumihiro Ishibashi, Hironobu Wada, Toshiko Kamata, Jiro Terada, Kenji Tsushima, Yuichiro Hayashi, Takayuki Shiomi, Kenta Takahashi, Tadaki Suzuki, Shigetoshi Yoshida. Bilobectomy for synchronous multiple lung cancer after COVID-19 pneumonia: a case report. AME case reports. 2022. 6. 13-13
Toshiko Kamata, Shigetoshi Yoshida, Mariko Takami, Fumie Ihara, Hiroko Yoshizawa, Takahide Toyoda, Yuichiro Takeshita, Seiichi Nobuyama, Yukiko Kanetsuna, Tetsuo Sato, et al. Immunological features of a lung cancer patient achieving an objective response with anti-programmed death-1 blockade therapy. Cancer science. 2020. 111. 1. 288-296
Fumie Ihara, Daiju Sakurai, Mariko Takami, Toshiko Kamata, Naoki Kunii, Kazuki Yamasaki, Tomohisa Iinuma, Toshinori Nakayama, Shinichiro Motohashi, Yoshitaka Okamoto. Regulatory T cells induce CD4- NKT cell anergy and suppress NKT cell cytotoxic function. Cancer immunology, immunotherapy : CII. 2019. 68. 12. 1935-1947
Kazuaki Harada, Fumie Ihara, Mariko Takami, Toshiko Kamata, Naoko Mise, Hiroko Yoshizawa, Tomoro Hishiki, Takeshi Saito, Keita Terui, Mitsuyuki Nakata, et al. Soluble factors derived from neuroblastoma cell lines suppress dendritic cell differentiation and activation. Cancer science. 2019. 110. 3. 888-902

ｍore...

MISC (36)：

Takahide Toyoda, Toshiko Kamata, Kazuhisa Tanaka, Fumie Ihara, Mariko Takami, Hidemi Suzuki, Takahiro Nakajima, Takayuki Ikeuchi, Yohei Kawasaki, Hideki Hanaoka, et al. Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer. Journal for immunotherapy of cancer. 2020. 8. 1
Yasuo Sekine, Takamasa Yun, Takahide Toyoda, Daisuke Kaiho, Eitetsu Koh, Toshiko Kamata. The Efficacy of Lung Volume Analyzer for Measuring Resection Margin in Pulmonary Segmentectomy for Malignant Diseases. JOURNAL OF THORACIC ONCOLOGY. 2017. 12. 1. S303-S303
鎌田稔子, 本橋新一郎, 吉田成利, 吉野一郎, 鈴木茜, 中山俊憲. PD-1/PDLの阻害によるヒトNKT細胞の機能への増強効果. 千葉医学雑誌. 2016. 92. 1. 32-32
鎌田稔子, 吉田成利, 吉野一郎, 中山俊憲, 本橋新一郎. 原発性肺癌に対するNKT細胞免疫治療と抗PD-1/PD-L1抗体併用療法の有用性. 千葉医学雑誌. 2014. 90. 6. 227-227
鎌田稔子, 鈴木茜, 藤川陽, 三瀬直子, 蒔田勇治, 吉田成利, 鈴木秀海, 中島崇裕, 岩田剛和, 吉野一郎, et al. 原発性肺癌に対するNKT細胞免疫療法におけるPD-1阻害の有用性. 肺癌. 2014. 54. 5. 563-563

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page